No Data
No Data
Aethlon Medical Files to Sell Common Stock, Warrants
Aethlon Medical Is Maintained at Buy by HC Wainwright & Co.
Aethlon Medical Is Maintained at Buy by HC Wainwright & Co.
HC Wainwright & Co. Maintains Buy on Aethlon Medical, Lowers Price Target to $10
HC Wainwright & Co. analyst Vernon Bernardino maintains Aethlon Medical (NASDAQ:AEMD) with a Buy and lowers the price target from $23 to $10.
Aethlon Medical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/04/2024 443.48% HC Wainwright & Co. $23 → $10 Maintains Buy 10/24/2023 1150% HC Wainwright & Co. $90 →
Analysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (CNTB), Aethlon Medical (AEMD) and Aclaris Therapeutics (ACRS)
Aethlon Medical Explores Synergies With Santersus Devices
No Data